SIREXATAMAB

UNII: RM898LZ4SI
Preferred Substance Name: SIREXATAMAB

2414962-49-3
ANTI-DKK-1 MONOCLONAL ANTIBODY LY2812176
DKK1-NEUTRALIZING MONOCLONAL ANTIBODY DKN-01
DKN 01 [WHO-DD]
DKN01
DKN-01
HUMANISED IGG4 ANTI DICKKOPF-1 PROTEIN MONOCLONAL ANTIBODY DKN-01
IMMUNOGLOBULIN G4 (224-PROLINE,233-ALANINE,234-ALANINE), ANTI-(HUMAN DICKKOPF-1) (HUMAN-MUS MUSCULUS MONOCLONAL DKN-01 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL DKN-01 .KAPPA.-CHAIN, DIMER
LY2812176
LY-2812176
SIREXATAMAB [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

SIREXATAMAB

Synonyms and Mappings

Resources

Note